Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
about
Forkhead box transcription factor O1 inhibits cholesterol 7alpha-hydroxylase in human hepatocytes and in high fat diet-fed miceNovel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver HomeostasisLifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsAnimal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and InflameAnimal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under DevelopmentDietary habits and behaviors associated with nonalcoholic fatty liver diseaseSIRT3 regulates progression and development of diseases of aging.Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in micePalmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondriaAcute low-dose endotoxin treatment results in improved whole-body glucose homeostasis in mice.Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosisTime-dependent network analysis reveals molecular targets underlying the development of diet-induced obesity and non-alcoholic steatohepatitis.Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis.Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis.Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatmentsβ-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in miceInduction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol.Redox control of liver function in health and diseaseTranslational approaches: from fatty liver to non-alcoholic steatohepatitis.Expression of fatty acid synthase in nonalcoholic fatty liver disease.Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in miceModeling progressive non-alcoholic fatty liver disease in the laboratory mouse.The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in miceTTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.Nuciferine prevents hepatic steatosis and injury induced by a high-fat diet in hamsters.CCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model.Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH.Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.Expression and function of methylthioadenosine phosphorylase in chronic liver disease.The metabolically benign and malignant fatty liver.Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease.Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.Liver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in Japanese patients with non-alcoholic fatty liver disease.Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice.Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.Nonalcoholic Steatohepatitis: A Search for Factual Animal Models.The role of metformin in the management of NAFLDMicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.
P2860
Q24654808-32A12B42-6B21-47FD-ADF5-1744ED82A9F5Q26746997-E507B0C3-C421-49FB-B549-1FEB73D80DD0Q26748608-6630435A-9BA5-479E-8852-A0D555A5B875Q26775571-931922FF-22D2-461A-BD32-EE9A66DC8B36Q26781761-4D3185B5-18F4-4A13-B6FF-218867326BB0Q26830594-325BB847-75DA-462A-91A7-1BD1A405C0F2Q26864656-E66623E3-FEF9-45C2-AE4B-13D0F13F1C72Q28507402-AD135DBC-5D9A-4EC1-8CA9-097FF3E39207Q28573343-FB4EF08C-EB5F-4938-B2E8-66026760B926Q30274807-66792F48-55B7-4EB8-8619-D14184700327Q30538670-2478CE82-AD58-4B4B-B8A1-18562F25B0BAQ30539316-38AE5836-F157-49F2-995E-9AF11A482831Q30841155-C95A3271-8C55-41A4-8B8E-8C66BC7BDEEFQ33566874-66D14AC0-8D1E-46EB-BAA3-4D68C3BB0D04Q33602167-C713BC4A-4D07-4B4D-B65C-7A39C62FD55AQ33616887-BBFD2A31-CA1B-455F-8723-9A79B74161E0Q33654923-D9203BE3-A6FF-4FB0-A602-149479F37320Q33678636-9D700151-8C3C-4CD4-A9CA-BE1AC902F8E3Q33830140-560CFE46-9085-445C-B629-320E9DFFF4E8Q33958697-C30124B1-22EB-43F0-AD54-E768576F0756Q33962008-CF4B66B1-3997-4760-989C-B1063443BDACQ34033317-F769EC86-0BBB-48D1-AA02-97DFF798BF58Q34185231-A60C2013-DAF4-4935-AF91-C42E891778D2Q34332185-8C9D2BC8-5483-472B-9DD4-25049E5F010DQ34397051-CB079A8A-2A48-414A-BB73-E1421244FC22Q34533119-D15BDEA6-FF85-418D-BB9C-8291A2F06BC3Q34730964-3DB1C19A-26EF-439F-BB95-EBF90C4DA7DBQ34769732-D9FDAA3D-A3F2-4EC4-B8EB-E024DDF12299Q35014238-FC307B34-5686-4843-BD79-3A4BED63753FQ35044164-FC38A257-E878-458C-9E65-003524C7CBAFQ35063777-92B07CBB-6D60-4D63-A993-F61E49373FA0Q35123495-688DF55B-BEE8-4BD7-9CA4-F6C3E65A7654Q35126355-3DA64606-27E7-4EBE-9C7C-0294C963E540Q35152196-C858ADD1-D4D4-4CAA-B361-73F1EDC83377Q35192172-14409AF2-BA8C-4104-A3F8-2D5478F235C9Q35535851-A7B5F773-BB3A-4750-99FA-2751A92A4FB6Q35562084-2C1F12D9-C2BB-43C1-B079-9F351DF64BDFQ35612535-7417D024-88B1-45B7-A7B3-AEED5C24C7A9Q35614956-31C5CD9F-3CC4-4E1D-BE3B-56018B8BB914Q35652509-5CAD805C-B6CA-45D3-AA0B-013010F3FD54
P2860
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
@en
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
@nl
type
label
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
@en
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
@nl
prefLabel
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
@en
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
@nl
P2093
P2860
P356
P1433
P1476
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
@en
P2093
Hirofumi Misu
Ken-Ichi Miyamoto
Masao Honda
Masayoshi Yokoyama
Naoto Matsuzawa
Seiichiro Kurita
Shuichi Kaneko
Toshinari Takamura
Tsuguhito Ota
Yasuni Nakanuma
P2860
P304
P356
10.1002/HEP.21874
P407
P50
P577
2007-11-01T00:00:00Z